J. Safra Sarasin Holding’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$2M	Buy	115,684 +68,588	+146%	+$1.19M	0.03%	217
2025 Q1	$1.03M	Sell	47,096 -13,251	-22%	-$290K	0.02%	318
2024 Q4	$1.93M	Sell	60,347 -13,230	-18%	-$422K	0.03%	224
2024 Q3	$2.12M	Buy	73,577 +36,034	+96%	+$1.04M	0.04%	204
2024 Q2	$1.44M	Buy	+37,543	New	+$1.44M	0.03%	288